Hepatocyte gene transfer mediated by stable polyplexes based on MPP-containing DNA complexes

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 5, 2009, Pages 498-503

  Yu, Bao Feng ^a   Li, Wan I ^b   Hu, Xiao Nian ^c   Zhang, Yue Hong ^a   Niu, Bo ^a   Xie, Jun ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Gene therapy; Hepatocyte; Membrane penetrating peptide; Protein transduction

Indexed keywords

CELL PENETRATING PEPTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; MEMBRANE PENETRATING PEPTIDE; POLYHISTIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONTROLLED STUDY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; REPORTER GENE;

ANIMALS; CELLS, CULTURED; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HISTIDINE; LIVER; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PLASMIDS;

EID: 70350282936     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Curiel DT, Gerritsen WR, Krul MR. Progress in cancer gene therapy. Cancer Gene Ther 2000;7:1197-1199.
2. Friedmann T. Progress toward human gene therapy. Science 1989;244:1275-1281. (Pubitemid 19170495)
3. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992;158:97-129.
4. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992;68:143-155.
5. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989;63:3822-3828. (Pubitemid 19205454)
6. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000;18:33-37.
7. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995;92:7297-7301.
8. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999;60:149-160.
9. Kircheis R, Blessing T, Brunner S, Wightman L, Wagner E. Tumor targeting with surface-shielded ligand - polycation DNA complexes. J Control Release 2001;72:165-170. (Pubitemid 32522354)
10. Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 2001;3:178-182.
11. Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, et al. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 2000;89:355-364. (Pubitemid 30152436)
12. Mahato RI. Non-viral peptide-based approaches to gene delivery. J Drug Target 1999;7:249-268. (Pubitemid 30098686)
13. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994;269:2550-2561. (Pubitemid 24235749)
14. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987;84:7413-7417.
15. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 1991;179:280-285.
16. Ito A, Miyazoe R, Mitoma J, Akao T, Osaki T, Kunitake T. Synthetic cationic amphiphiles for liposome-mediated DNA transfection. Biochem Int 1990;22:235-241.
17. Smith JG, Walzem RL, German JB. Liposomes as agents of DNA transfer. Biochim Biophys Acta 1993;1154:327-340.
18. Huckett B, Ariatti M, Hawtrey AO. Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of NEO into HepG2 cells.Biochem Pharmacol 1990;40:253-263.
19. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem 1992;3:533-539.
20. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A 1990;87:3410-3414. (Pubitemid 20173645)
21. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987;262:4429-4432.
22. Armeanu S, Pelisek J, Krausz E, Fuchs A, Groth D, Curth R, et al. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther 2000;1:366-375.
23. Wolschek MF, Thallinger C, Kursa M, Rössler V, Allen M, Lichtenberger C, et al. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 2002;36:1106-1114. (Pubitemid 35253426)
24. Domashenko A, Gupta S, Cotsarelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000;18:420-423. (Pubitemid 30217530)
25. Young JL, Dean DA. Nonviral gene transfer strategies for the vasculature. Microcirculation 2002;9:35-49.
26. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
27. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994;269:10444-10450. (Pubitemid 24198241)
28. Guo Y, Cheng NL, Wang XX, Liu ZZ, Xie J. hPer1-NLS: study of a novel penetrating peptide. J Shanxi Med Univ 2002;33:197-198.
29. Yang XL, Xie J, Niu B, Hu XN, Gao Y, Xiang Q, et al. Structure analysis of the protein transduction domain of human Period1 and its mutant analogs. J Mol Graph Model 2005;23:389-394. (Pubitemid 40386868)
30. Rawat A, Vaidya B, Khatri K, Goyal AK, Gupta PN, Mahor S, et al. Targeted intracellular delivery of therapeutics: an overview. Pharmazie 2007;62:643-658. (Pubitemid 47507836)
31. Xie J, Zhang YH, Yu BF, Chen XJ, Xu J, Hu XN, et al. Construction of hepatocyte specific gene therapy vector and its function of delivering gene into cells. China Biotechnol 2004;24:63-67.
32. Seglen PO. Incorporation of radioactive amino acids into protein in isolated rat hepatocytes. Biochim Biophys Acta 1976;442:391-404.
33. Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, et al. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther 2001;3:310-318. (Pubitemid 32514646)
34. Yoon HY, Lee SH, Cho SW, Lee JE, Yoon CS, Park J, et al. TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem Int 2002;41:37-42. (Pubitemid 34251404)
35. Laufer SD, Restle T. Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems. Curr Pharm Des 2008;14:3637-3655.
36. Trabulo S, Mano M, Faneca H, Cardoso AL, Duarte S, Henriques A, et al. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA. J Gene Med 2008;10:1210-1222.
37. Foged C, Franzyk H, Bahrami S, Frokjaer S, Jaroszewski JW, Nielsen HM, et al. Cellular uptake and membrane-destabilising properties of alpha-peptide/beta-peptoid chimeras: lessons for the design of new cell-penetrating peptides. Biochim Biophys Acta 2008;1778:2487-2495.
38. Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjug Chem 2008;19:1526-1534.
39. Lo SL, Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008;29:2408-2414.
40. Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 2008;60:530-536.
41. Moschos SA, Williams AE, Lindsay MA. Cell-penetrating-peptide-mediated siRNA lung delivery. Biochem Soc Trans 2007;35:807-810.
42. Abes R, Arzumanov AA, Moulton HM, Abes S, Ivanova GD, Iversen PL, et al. Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans 2007;35:775-779.
43. Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos- Sternberg B, D'Souza GG. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A 2003;100:1972-1977. (Pubitemid 36254558)
44. Rudolph C, Plank C, Lausier J, Schillinger U, Müller RH, Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003;278:11411-11418. (Pubitemid 36792699)
45. Xie J, Yu BF, Xu J, Zhang YH, Cheng NL, Niu B, et al. Protein transduction domain of membrane penetrating peptide can efficiently deliver DNA and protein into mouse liver for gene therapy. Hepatobiliary Pancreat Dis Int 2005;4:90-93. (Pubitemid 40347522)